These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8470693)

  • 1. Visual compatibility of ciprofloxacin with selected components of total parenteral nutrient solutions during simulated Y-site injection.
    Percy LA; Rho JP
    Am J Hosp Pharm; 1993 Apr; 50(4):715-6. PubMed ID: 8470693
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual compatibility of ciprofloxacin lactate with five broad-spectrum antimicrobial agents during simulated Y-site injection.
    Tucker DR; Sieradzan R
    Am J Hosp Pharm; 1988 Sep; 45(9):1910-1. PubMed ID: 3228127
    [No Abstract]   [Full Text] [Related]  

  • 3. Visual compatibility of ganciclovir sodium and total parenteral nutrient solution during simulated Y-site injection.
    Outman WR; Mitrano FP; Baptista RJ
    Am J Hosp Pharm; 1991 Jul; 48(7):1538-9. PubMed ID: 1909095
    [No Abstract]   [Full Text] [Related]  

  • 4. Visual compatibility of sargramostim with selected antineoplastic agents, anti-infectives, or other drugs during simulated Y-site injection.
    Trissel LA; Bready BB; Kwan JW; Santiago NM
    Am J Hosp Pharm; 1992 Feb; 49(2):402-6. PubMed ID: 1554007
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro stability of amikacin and ciprofloxacin administered through a Y-shaped catheter connection with 2 total parenteral nutrition formulations with different pH].
    Balet A; Cardona D; Pastor C; Márquez M
    Nutr Hosp; 1990; 5(2):108-11. PubMed ID: 2127703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility and availability of sodium bicarbonate in total parenteral nutrient solutions.
    Henann NE; Jacks TT
    Am J Hosp Pharm; 1985 Dec; 42(12):2718-20. PubMed ID: 3002174
    [No Abstract]   [Full Text] [Related]  

  • 7. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
    Trissel LA; Tramonte SM; Grilley BJ
    Am J Hosp Pharm; 1991 May; 48(5):988-92. PubMed ID: 1830190
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
    Trissel LA; Chandler SW; Folstad JT
    Am J Hosp Pharm; 1990 Nov; 47(11):2525-8. PubMed ID: 2278268
    [No Abstract]   [Full Text] [Related]  

  • 9. Visual compatibility of enalaprilat with selected intravenous medications during simulated Y-site injection.
    Thompson DF; Allen LV; Stiles ML
    Am J Hosp Pharm; 1990 Nov; 47(11):2530-1. PubMed ID: 2177585
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium and phosphorus compatibility in parental nutrition solutions for neonates.
    Eggert LD; Rusho WJ; MacKay MW; Chan GM
    Am J Hosp Pharm; 1982 Jan; 39(1):49-53. PubMed ID: 6798868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of hydromorphone hydrochloride in large-volume parenterals.
    Cutie MR; Waranis R
    Am J Hosp Pharm; 1982 Feb; 39(2):307-8. PubMed ID: 6174044
    [No Abstract]   [Full Text] [Related]  

  • 12. Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection.
    Souney PF; Colucci RD; Mariani G; Campbell D
    Am J Hosp Pharm; 1984 Feb; 41(2):323-4. PubMed ID: 6702842
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium and phosphate solubility curves for parenteral nutrient solutions containing Vaminolact.
    Mo-Suwan L; Puetpaiboon A; Apiromrak B
    J Med Assoc Thai; 1997 Aug; 80(8):516-20. PubMed ID: 9277084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual compatibility of fentanyl citrate with selected drugs during simulated Y-site injection.
    Marquardt ED; Lam SS
    Am J Hosp Pharm; 1994 Mar; 51(6):811-2. PubMed ID: 8010323
    [No Abstract]   [Full Text] [Related]  

  • 15. Stability of cimetidine hydrochloride in parenteral nutrition solutions.
    Tsallas G; Allen LC
    Am J Hosp Pharm; 1982 Mar; 39(3):484-5. PubMed ID: 6803588
    [No Abstract]   [Full Text] [Related]  

  • 16. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
    Nieves-Cordero AL; Luciw HM; Souney PF
    Am J Hosp Pharm; 1985 May; 42(5):1108-9. PubMed ID: 4003421
    [No Abstract]   [Full Text] [Related]  

  • 18. Compatibility of drugs with a heparin-containing neonatal total parenteral nutrient solution.
    Schilling CG
    Am J Hosp Pharm; 1988 Feb; 45(2):313-4. PubMed ID: 3129935
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Jun; 45(6):1357-8. PubMed ID: 3414706
    [No Abstract]   [Full Text] [Related]  

  • 20. Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
    Trissel LA; Parks NP; Santiago NM
    Am J Hosp Pharm; 1991 Oct; 48(10):2186-9. PubMed ID: 1781478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.